PORTANT pub lic health prob lem, and out breaks of per tus sis con tinue to oc cur in Can ada. In 1992, over 3700 cases of pertus sis in fec tion were re ported in Can ada (1). Moreo ver, 7049 and 3218 cases of per tus sis were re ported for 1993 and the first half of 1994, re spec tively, in di cat ing a rise in the in cidence of this dis ease in Can ada (per sonal com mu ni ca tion). The in ci dence of this dis ease var ies by age group, but is highest in in fants less than a year old, with an an nual rate reach ing one case per 1000. The in ci dence of per tus sis in ado les cents and adults is un der re ported, in part be cause symp toms are of ten less char ac ter is tic than with child hood dis ease. Yet adoles cents and adults act as an im por tant res er voir for trans mitting dis ease to sus cep ti ble popu la tions of young chil dren (2,3). Re cently, the first case of B per tus sis dis ease caused by a strain highly re sis tant to eryth ro my cin, the an ti bi otic of choice against per tus sis, was re ported in the United States (4). It is es ti mated that ap proxi mately 0.04% of in fected children in de vel oped coun tries die every year from this dis ease and its con se quences, es pe cially pneu mo nia (1). In gen eral, the cur rently used whole-cell per tus sis vac cines are ef fi cacious as in di cated by a re duc tion of 93% in an nual in ci dence com pared with the pre vac cine pe riod. How ever, per tus sis is still a ma jor con cern and was ranked as the fifth pri or ity disease for na tional sur veil lance by the Ca na dian Ad vi sory Commit tee on Epi de mi ol ogy. In 1993, a con sen sus con fer ence on per tus sis was spon sored by the Child hood Im mu ni za tion Di vision, Bu reau of Com mu ni ca ble Dis ease Epi de mi ol ogy, Labora tory Cen tre for Dis ease Con trol (LCDC) to es tab lish na tional goals and rec om men da tions for the con trol of per tus sis. One of the rec om men da tions spe cifi cally stated that the de vel opment and stan dardi za tion of rapid di ag nos tic tests were urgently re quired.
I NFEC TION WITH BOR DE TELLA PER TUS SIS IS STILL AN IM -
PORTANT pub lic health prob lem, and out breaks of per tus sis con tinue to oc cur in Can ada. In 1992, over 3700 cases of pertus sis in fec tion were re ported in Can ada (1) . Moreo ver, 7049 and 3218 cases of per tus sis were re ported for 1993 and the first half of 1994, re spec tively, in di cat ing a rise in the in cidence of this dis ease in Can ada (per sonal com mu ni ca tion). The in ci dence of this dis ease var ies by age group, but is highest in in fants less than a year old, with an an nual rate reach ing one case per 1000. The in ci dence of per tus sis in ado les cents and adults is un der re ported, in part be cause symp toms are of ten less char ac ter is tic than with child hood dis ease. Yet adoles cents and adults act as an im por tant res er voir for trans mitting dis ease to sus cep ti ble popu la tions of young chil dren (2, 3) . Re cently, the first case of B per tus sis dis ease caused by a strain highly re sis tant to eryth ro my cin, the an ti bi otic of choice against per tus sis, was re ported in the United States (4). It is es ti mated that ap proxi mately 0.04% of in fected children in de vel oped coun tries die every year from this dis ease and its con se quences, es pe cially pneu mo nia (1) . In gen eral, the cur rently used whole-cell per tus sis vac cines are ef fi cacious as in di cated by a re duc tion of 93% in an nual in ci dence com pared with the pre vac cine pe riod. How ever, per tus sis is still a ma jor con cern and was ranked as the fifth pri or ity disease for na tional sur veil lance by the Ca na dian Ad vi sory Commit tee on Epi de mi ol ogy. In 1993, a con sen sus con fer ence on per tus sis was spon sored by the Child hood Im mu ni za tion Di vision, Bu reau of Com mu ni ca ble Dis ease Epi de mi ol ogy, Labora tory Cen tre for Dis ease Con trol (LCDC) to es tab lish na tional goals and rec om men da tions for the con trol of per tus sis. One of the rec om men da tions spe cifi cally stated that the de vel opment and stan dardi za tion of rapid di ag nos tic tests were urgently re quired.
Iso la tion of B per tus sis from na so pha ryn geal swabs or aspi ra tions re mains the 'gold stan dard' for the di ag no sis of pertus sis in fec tion (5) . This method is highly spe cific but is time-consuming, la bour in ten sive and re sults are ob tained only af ter four to seven days of cul ture on spe cial ized me dia. Cul ture is avail able in many clini cal labo ra to ries but has a low sen si tiv ity of 40 to 60% (5) . Se ro logi cal analy sis by a va ri ety of meth ods is avail able, but the re quire ment for se ro con ver sion gen er ally de lays the de tec tion of pertussis-specific an ti bod ies be yond the time by which di ag no sis is re quired (2, 6) . These se ro logi cal as says are bet ter suited for epi de mi ol ogi cal studies of per tus sis in fec tions. Po lymerase chain re ac tion (PCR)-based iden ti fi ca tion sys tems are un der de vel op ment and evalua tion, but are not read ily avail able (7) . These assays will likely be come es sen tial tools for the di ag no sis of pertus sis in the fu ture and will proba bly have a de tec tion ca pa bil ity be yond that ob served for cul ture.
Di rect im mu no fluo res cent as say with poly va lent se rum is used to ob tain an early pre sump tive di ag no sis or to con firm cul ture. How ever, cross-reactions of the poly va lent se rum with other bac te rial spe cies or other an ti gens pres ent in the clini cal speci men have re sulted in a very high in ci dence of false posi tive re sults, with rates as high as 85% de pend ing on the ex per tise of the clini cal labo ra tory per son nel (6) . One way to im prove sig nifi cantly the per form ance of di rect im mu no fluores cent as say is to de velop highly spe cific im mu no logi cal reagents, such as high af fin ity mono clonal an ti bod ies (MAbs). Al ready, MAb-based di ag nos tic tests are be ing used with great suc cess in clini cal labo ra to ries. Iden ti fi ca tion of the most suit able tar get an ti gen(s) for a par ticu lar di ag nos tic test is a key step in the suc cess ful produc tion of highly spe cific MAbs. The lipo-oligosaccharide (LOS) of B per tus sis is a de sir able an ti gen for such a pur pose be cause it is one of the es sen tial com po nents of the outer mem brane and is there fore pres ent at the sur face of all or ganisms iso lated from ac tive in fec tion. A se ries of MAbs, named BL-1 to BL-7, which rec og nize the LOS of B per tus sis and do not cross-react with other na so pha ryn geal bac te ria, was devel oped by the Na tional Labo ra tory for Im mu nol ogy, LCDC (8). Sub se quently, one of these MAbs was used to gen er ate a spe cific fluorescein-labelled im mu no logi cal rea gent for di rect im mu no fluo res cent as say.
The unique an ti genic site rec og nized by the MAbs is located on three amino sug ars of the car bo hy drate por tion of B per tus sis LOS (9) . This re ac tive site is an ti geni cally very sta ble and highly con served among all B per tus sis iso lates re gardless of physio logi cal state. Only very rare labo ra tory LOS variant strains do not have these three amino sug ars on the LOS mole cule and are there fore not rec og nized by the MAbs. A ra dioim munobind ing as say was used to dem on strate that this an ti genic site is freely ac ces si ble at the sur face of in tact bac te ria and could be de tected di rectly in clini cal speci mens with out the need to dis rupt par tially cell in teg rity . Two sub sequent ex peri ments, in vi tro bac te ri cidal as say and pro tec tion in ani mal aero sol model, fur ther dem on strated the im por tance and the sur face ac ces si bil ity of this an ti genic site (10, 11) .
To de velop a di rect im mu no fluo res cent as say, one of these MAbs was pu ri fied and sub se quently cou pled to fluorescein-isothiocyanate. The fluorescein-labelled MAb was first tested against a panel of B per tus sis strains ob tained af ter cul ture on Bordet-Gengou agar, as well as other bac terial spe cies nor mally found in the na so pha rynx. It was observed that a block ing step with 10% rab bit se rum elimi nated the non spe cific bind ing of the MAb Fc re gion to re cep tors found on cer tain bac te rial cells. The la belled MAb spe cifi cally rec og nized all 64 B per tus sis clini cal iso lates with out any cross-reaction with Bor de tella parap er tus sis or any other bacte rial spe cies nor mally iso lated from the res pi ra tory tract. Weakly fluo res cent bac te rial cells were ob served when the labelled MAb was in cu bated with Bor de tella bron chisep tica strains. This re ac tiv ity was not sur pris ing since an ti genic re lation ships be tween the LOS of B per tus sis and the lipo poly saccha ride of B bron chisep tica have been pre vi ously re ported (9) . B bron chisep tica is an ani mal patho gen that rarely causes in fec tion in hu mans ex posed to in fected ani mals (12).
The Cad ham Pro vin cial Labo ra tory in Mani toba in col labora tion with the Na tional Labo ra tory for Im mu nol ogy are evaluat ing the sen si tiv ity and speci fic ity of this im mu no logi cal rea gent di rectly with clini cal speci mens ob tained dur ing an out break of per tus sis. The study is de signed to com pare culture with the di rect de tec tion of B per tus sis on smears obtained from na so pha ryn geal swabs by the fluorescein-labelled MAb. Al ready, 1398 smears have been tested and pre limi nary re sults in di cate that the sen si tiv ity of the di rect im mu no fluo res cent as say com pared with cul ture is 65%, while the speci fic ity re corded is as high as 99.6%. This lat ter re sult sug gests that the use of a more re fined im mu nologi cal rea gent can sig nifi cantly in crease the speci fic ity of direct im mu no fluo res cent as say com pared with the re sults ob tained with fluorescein-labelled poly va lent an tis era. It is impor tant to note that only five of the 1398 speci mens tested gave posi tive re sults while the cul ture re mained nega tive. To ver ify whether B pertus sis cells are pres ent or ab sent on these slides, each sam ple is eluted and then tested by PCR. Re cently, it was ob served that pa tients for whom di ag no sis of in fec tious dis eases was made more rap idly had a sig nificantly lower mor tal ity rate (13) . Fur ther more, rapid di ag no sis of B per tus sis helps not only to im prove treat ment, but also to ini ti ate che mo pro phy laxis rap idly to close con tacts of the patient (14). For these rea sons, we are also de vel op ing an ultrara pid auto mated as say us ing flow cy tome try in col labo ra tion with the De part ment of Mi cro bi ol ogy and Im munol ogy of the Ste-Justine Hos pi tal in Mont real. There are two ma jor ad van tages to an auto mated as say over tra di tional direct im mu no fluo res cent as say. First is a sig nifi cant in crease in ac cu racy be cause the read ings would be stan dard ized, repro duci ble and not de pend on the com pe tence of a spe cialized tech nolo gist. Sec ond would be a no tice able re duc tion in the time nor mally re quired to pro cess and ana lyze a specimen.
Flow cy tome try can be eas ily adapted for the ac cu rate detec tion of B per tus sis cells di rectly in clini cal speci mens. Flow cy tome ters are de signed to count par ti cles ef fi ciently by size and pro tein con tent us ing light scat ter ing. In our case, the instru ment was ad justed by pre limi nary ex peri ments to de tect par ti cles match ing B per tus sis cell size and nu cleic acid content. To in crease the speci fic ity of the test, the fluoresceinlabelled MAb is then used to tag the B per tus sis or gan isms. Thus, only fluo res cent B per tus sis cells are counted. All other par ti cles are ig nored.
To date, 125 clini cal sam ples ob tained from pa tients with clini cal signs com pati ble with per tus sis in fec tion have been proc essed and ana lyzed us ing a flow cy tome ter. These analy ses fa cili tated op ti miz ing the pro ce dure to ob tain the best re sults with a mini mum number of steps. It was noted that the bac te ria pres ent in na so pha ryn geal swabs could be di rectly sus pended in phosphate-buffered sa line. On the contrary, the mu coid sub stances al ways pres ent in the na so pharyn geal as pi ra tions had to be liq ui fied with dithio threi tol and then fil tered be fore they could be la belled by the MAb. The flow cy tome ter was al ways cali brated with stan dard ized positive and nega tive con trols to ob tain com pa ra ble read ings from one run to an other. Pre limi nary re sults in di cate that this ultrara pid auto mated fluo res cent as say (less than 45 mins from be gin ning to end) is at least as sen si tive as cul ture. Moreo ver, sev eral culture-negative sam ples were clearly cate go rized as posi tive by this as say, sug gest ing that this as say may be more sen si tive than cul ture. PCR am pli fi ca tion of B per tus sis DNA will again be used to con firm the pres ence of B per tus sis cells not de tected by cul ture. These pre limi nary ex peri ments clearly sug gest that it is pos si ble to use this auto mated as say to iden tify B per tus sis rap idly -within an hour -giv ing the clini cian ad di tional cri te ria to es tab lish an early di ag no sis. This auto mated pro cess may be very use ful for the rapid screen ing of large num bers of sam ples dur ing ma jor out breaks.
